Bilezikian JP et al. Oct., Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–3569. https://doi.org/10.1210/jc.2014-1413

Barczyński M, Bränström R, Dionigi G, Mihai R. Sporadic multiple parathyroid gland disease—a consensus report of the European society of endocrine surgeons (ESES). Langenbeck’s Archives Surgery. 2015;400(8):887–905. https://doi.org/10.1007/s00423-015-1348-1

Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115–125. https://doi.org/10.1038/nrendo.2017.104

Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391(10116):168–178. https://doi.org/10.1016/S0140-6736(17)31430-7

Anastasilakis DA, Makras P, Polyzos SA, Anastasilakis AD. Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview. Hormones. 2019;18(1):65–70. https://doi.org/10.1007/s42000-018-0069-6.

Article  PubMed  Google Scholar 

Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: differential diagnosis and treatment. CA Cancer J Clin. 2018;68(5):377–386. https://doi.org/10.3322/caac.21489

Han CH, Fry CH, Sharma P, Han TS. A clinical perspective of parathyroid hormone related hypercalcaemia. Rev Endocrine Metabolic Disorders. 2020;21(1):77–88. https://doi.org/10.1007/s11154-019-09529-5

Lee JY, Shoback DM. Familial hypocalciuric hypercalcemia and related disorders. Best Pract Res Clin Endocrinol Metab. 2018;32(5):609–19. https://doi.org/10.1016/j.beem.2018.05.004.

Cetani F, Pardi E, Marcocci C. Parathyroid carcinoma. Front Horm Res. 2018;51:63–76. https://doi.org/10.1159/000491039.

Article  PubMed  CAS  Google Scholar 

Kandil E, Noureldine S, Khalek MA, Daroca P, Friedlander P. Ectopic secretion of parathyroid hormone in a neuroendocrine tumor: a case report and review of the literature. Int J Clin Exp Med. 2011;4(3):234–40.

PubMed  PubMed Central  CAS  Google Scholar 

Palumbo VD, Damiano G, Messina M, Fazzotta S, Lo G, Monte, Monte AIL. Tertiary hyperparathyroidism: a review. Clin Ter. 2021;72(01):241–6. https://doi.org/10.7417/CT.2021.2322. no. 3Societa Editrice Universo.

Cipriani C, Bilezikian JP. Three generational phenotypes of sporadic primary hyperparathyroidism: evolution defined by technology. Lancet Diab Endocrinol. 2019;7(10):745–747. https://doi.org/10.1016/S2213-8587(19)30188-3

Castellano E, et al. Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J Clin Endocrinol Metab. 2017;102(11):4148–52. https://doi.org/10.1210/jc.2017-01080.

Article  PubMed  Google Scholar 

Rubin MR et al. Sep., The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years. J Clin Endocrinol Metab. 2008;93(9):3462–3470. https://doi.org/10.1210/jc.2007-1215

Minisola RV, Arnold S, Belaya A, Brandi Z, Clarke ML, Hannan B, Hofbauer FM, Insogna L, Lacroix K, Liberman A, Palermo U, Pepe A, Rizzoli J, Wermers R, R. and, Thakker. Epidemiology, pathophysiology and genetics of primary hyperparathyroidism. J Bone Miner Res. 2022. https://doi.org/10.1002/JBMR.4665

Marcocci C, et al. Italian society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J Endocrinol Invest. Apr. 2015;38(5):577–93. https://doi.org/10.1007/s40618-015-0261-3.

Corbetta S. Normocalcemic hyperparathyroidism. Front Horm Res. 2018;51:23–39. https://doi.org/10.1159/000491036.

Article  PubMed  CAS  Google Scholar 

Palermo A, et al. Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab. 2020;105(7). https://doi.org/10.1210/clinem/dgaa174.

Zavatta G, Clarke BL. Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach. Endocrinol Metab. 2021;36(3):525–535. https://doi.org/10.3803/ENM.2021.1061

Halimi C, et al. Comparison of normocalcemic vs hypercalcemic primary hyperparathyroidism in a Hypercalciuric renal stone population. J Clin Endocrinol Metab. 2024. https://doi.org/10.1210/clinem/dgae162.

Trébouet E et al. Jun., Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate. Langenbeck’s Arch. Surg. 2019;404(4):431–438. https://doi.org/10.1007/s00423-019-01782-1

Nabata KJ, Wiseman JJ, Wiseman SM. Normohormonal primary hyperparathyroidism: A systematic review and meta-analysis. Am J Surg. 2023;226(2):186–196. https://doi.org/10.1016/j.amjsurg.2023.04.004

Armstrong VL, et al. Phenotypes of primary hyperparathyroidism: does parathyroidectomy improve clinical outcomes for all? Surg (United States). 2023;173(1):173–9. https://doi.org/10.1016/j.surg.2022.05.042.

Fedorova T, Hagglund K, Hawasli A. The normohormonal primary hyperparathyroidism; a surgical dilemma pre and intra-operatively. Am J Surg. 2022;223(3):589–591. https://doi.org/10.1016/j.amjsurg.2022.01.002

Applewhite MK et al. Jan., Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery (United States). 2017;161(1):62–69. https://doi.org/10.1016/j.surg.2016.03.038

Minisola S, Gianotti L, Bhadada S, Silverberg SJ. Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):791–803. https://doi.org/10.1016/j.beem.2018.09.001

Saponaro F et al. Nov., Clinical presentation and management of patients with primary hyperparathyroidism in Italy. J Endocrinol Invest. 2018;41(11):1339–1348. https://doi.org/10.1007/s40618-018-0879-z

Minisola S, Pepe J, Scillitani A, Cipriani C. Explaining geographical variation in the presentation of primary hyperparathyroidism. Lancet Diabetes Endocrinol. 2016;4(8):641–3. https://doi.org/10.1016/S2213-8587(16)00076-0

Carnevale V, et al. Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin Endocrinol (Oxf). 2004;60(1):81–6. https://doi.org/10.1111/j.1365-2265.2004.01946.x.

Xie C, Tsakok M, Taylor N, Partington K. Imaging of brown tumours: a pictorial review. Insights into Imaging. 2019;10(1). https://doi.org/10.1186/s13244-019-0757-z

Bilezikian JP, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metabolism. 2002;87(12):5353–61. https://doi.org/10.1210/jc.2002-021370.

Makras P, Anastasilakis AD. Bone disease in primary hyperparathyroidism. Metabolism. 2018;80:57–65. https://doi.org/10.1016/j.metabol.2017.10.003.

Vignali E, et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 2009;94(7):2306–12. https://doi.org/10.1210/jc.2008-2006.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Silva BC, et al. Trabecular bone score (TBS)-A novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2013;98(5):1963–70. https://doi.org/10.1210/jc.2012-4255.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stein EM, et al. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Min Res. 2013;28(5):1029–40. https://doi.org/10.1002/jbmr.1841.

Article  Google Scholar 

Tabacco G, et al. DXA-Based bone strain index: a New Tool to Evaluate Bone Quality in primary hyperparathyroidism. J Clin Endocrinol Metab. 2021;106(8):2304–12. https://doi.org/10.1210/clinem/dgab317.

Naciu AM, et al. Bone quality as measured by trabecular bone score in normocalcemic primary hyperparathyroidism. Endocr Pract. 2021;27(10):992–7. https://doi.org/10.1016/j.eprac.2021.04.884.

Tabacco G, et al. DXA-based bone strain index in normocalcemic primary hyperparathyroidism. Osteoporos Int. 2023;34(5):999–1003. https://doi.org/10.1007/s00198-023-06669-y.

Castellano E, Attanasio R, Boriano A, Borretta G. Clinical presentation of primary hyperparathyroidism in older adults. J Endocr Soc. 2019;3(12):2305–2312. https://doi.org/10.1210/js.2019-00316

Cassibba S, et al. Silent renal stones in primary hyperparathyroidism: prevalence and clinical features. Endocr Pract. Nov. 2014;20(11):1137–42. https://doi.org/10.4158/EP14074.OR.

Cipriani C et al. Apr., Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab. 2015;100(4):1309–1315. https://doi.org/10.1210/jc.2014-3708

Saponaro F, et al. Hypomagnesuria is Associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2020;105(8). https://doi.org/10.1210/clinem/dgaa233.

Gurrado A, Piccinni G, Lissidini G, Di Fronzo P, Vittore F, Testini M. Hypercalcaemic crisis due to primary hyperparathyroidism - a systematic literature review and case report. Endokrynol Pol. 2012;63(6):494–502.

PubMed  Google Scholar 

Vestergaard P. Primary hyperparathyroidism and nephrolithiasis. Ann Endocrinol (Paris). 2015;76(2):116–9. https://doi.org/10.1016/j.ando.2015.03.002.

Abboud B, Daher R, Boujaoude J. Digestive manifestations of parathyroid disorders. World J Gastroenterol. 2011;17(36):4063–4066. https://doi.org/10.3748/wjg.v17.i36.4063

Chiodini I, Cairoli E, Palmieri S, Pepe J, Walker MD. Non classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):805–20. https://doi.org/10.1016/j.beem.2018.06.006.

Pappu R, Jabbour SA, Regianto AM, Reginato AJ. Musculoskeletal manifestations of primary hyperparathyroidism. Clin Rheumatol. 2016;35(12):3081–3087. https://doi.org/10.1007/s10067-016-3450-3

Yashiro T, et al. Prevalence of Chondrocalcinosis in patients with primary hyperparathyroidism in Japan. Endocrinol Jpn. 1991;38(5):457–64. https://doi.org/10.1507/endocrj1954.38.457.

Article  PubMed  CAS  Google Scholar 

Webb SM, et al. Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2016;101(4):1571–8. https://doi.org/10.1210/jc.2015-3094.

Nelson JA, Alsayed M, Milas M. The role of parathyroidectomy in treating hypertension and other cardiac manifestations of primary hyperparathyroidism. Gland Surg. 2020;9(1):136–41. https://doi.org/10.21037/gs.2019.12.12.

Pepe J, Cipriani C, Sonato C, Raimo O, Biamonte F, Minisola S. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017;177(6):R297–R308. https://doi.org/10.1530/EJE-17-0485.

McMahon DJ et al. Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis, J Clin Endocrinol Metab. 2015;100(12):4399–4407. https://doi.org/10.1210/jc.2015-3202

Yavari M, Feizi A, Haghighatdoost F, Ghaffari A, Rezvanian H. The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis. Endocrine. 2021;72(1):72–85. https://doi.org/10.1007/s12020-020-02519-7

Gianotti L, et al. Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2014;81(3):350–5. https://doi.org/10.1111/cen.12472.

Article  PubMed  CAS  Google Scholar 

Frey S, Mirallié E, Cariou B, Blanchard C. Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: a narrative review. Nutrition Metab Cardiovascular Dis. 2021;31(4):981–96. https://doi.org/10.1016/j.numecd.2020.12.029.

Wilhelm SM, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959–68. https://doi.org/10.1001/jamasurg.2016.2310.

Bollerslev J et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Eur J Endocrinol. 2022;186(2):R33–R63. https://doi.org/10.1530/EJE-21-1044

Perrier N et al. Surgical aspects of primary hyperparathyroidism. J Bone Miner Res. 2022;37(11):2373–2390. https://doi.org/10.1002/jbmr.4689

Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665–72. https://doi.org/10.1097/00000658-200205000-00008.

Article  PubMed  PubMed Central  Google Scholar 

McIntyre CJ, Allen JLY, Constantinides VA, Jackson JE, Tolley NS, Palazzo FF. Patterns of disease in patients at a tertiary referral centre requiring reoperative parathyroidectomy. Ann R Coll Surg Engl. 2015;97(8):598–602. https://doi.org/10.1308/rcsann.2015.0039.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Parikh AM, Suliburk JW, Morón FE. Imaging localization and surgical approach in the management of ectopic parathyroid adenomas. Endocr Pract. 2018;24(01):589–98. https://doi.org/10.4158/EP-2018-0003. 6. American Association of Clinical Endocrinologists.

Article  PubMed  Google Scholar 

Gómez-Ramírez J, Gómez-Valdazo A, Luengo P, Porrero B, Osorio I, Rivas S. Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form? Am. J. Surg. 2020;219(1):150–153. https://doi.org/10.1016/j.amjsurg.2019.10.032

Cunha-Bezerra P, et al. Better performance of four-dimension computed tomography as a localization procedure in normocalcemic primary hyperparathyroidism. J Med Imaging Radiat Oncol. 2018;62(4):493–8. https://doi.org/10.1111/1754-9485.12728.

Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with 99mtechnetium sestamibi scintigraphy. Clin Endocrinol (Oxf). 2002;57(2):241–9. https://doi.org/10.1046/j.1365-2265.2002.01583.x.

Article  PubMed  Google Scholar 

Sacks BA, Pallotta JA, Cole A, Hurwitz J. Diagnosis of parathyroid adenomas: efficacy of measuring parathormone levels in needle aspirates of cervical masses. Am J Roentgenol. 1994;163(5):1223–6. https://doi.org/10.2214/ajr.163.5.7976905.

Article  CAS  Google Scholar 

Ketha H, Lasho MA, Algeciras-Schimnich A. Analytical and clinical validation of parathyroid hormone (PTH) measurement in fine-needle aspiration biopsy (FNAB) washings. Clin Biochem. 2016;49(1):16–21. https://doi.org/10.1016/j.clinbiochem.2015.09.006.

Bentrem DJ, Angelos P, Talamonti MS, Nayar R. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for